Navigation Links
CeNeRx BioPharma Finalizes Plans to Initiate Phase II Trials for Its Novel Antidepressant Agent Tyrima(TM) Using Innovative Brain Imaging Study
Date:7/22/2008

pipeline of selective cannabinoid compounds that have recently completed successful preclinical proof-of-concept studies for the treatment of pain, glaucoma and obesity. More information about CeNeRx BioPharma can be found at http://www.cenerx.com.

Contact:

GendeLLindheim BioCom Partners

Barbara Lindheim

212 918 4650


'/>"/>
SOURCE CeNeRx BioPharma
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine technology :

1. CeNeRx BioPharma Announces Successful Completion of Phase l Clinical Program for Novel Antidepressant Agent Tyrima(TM)
2. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
3. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
4. Nabi Biopharmaceuticals Announces Continued Positive NicVAX Phase 2b Data at Nine Months
5. Keryx Biopharmaceuticals to Present at William Blair & Company Small-Cap Growth Stock Conference
6. Morria Biopharmaceuticals Plc Initiates Phase I Clinical Study of MRX-4 in Allergic Rhinitis
7. Keryx Biopharmaceuticals, Inc. Announces Positive Preliminary Phase 2 Data on KRX-0401 in Patients with Chemo-Insensitive Rare Sarcoma
8. Nabi Biopharmaceuticals Announces Successful Completion of NicVAX(R) Phase 2b Trial; Drug Shows Statistically Significant Rates of Smoking Cessation and Continuous Long-Term Smoking Abstinence at 12 Months
9. Inspiration Biopharmaceuticals Announces Filing of IND for Novel Recombinant Factor IX Product, IB1001, for the Treatment of Hemophilia B
10. Immunosyn Announces Biozyme Labs Receipt of MHRA Manufacturing License Approval in Europe for the Biopharmaceutical SF-1019
11. Keryx Biopharmaceuticals, Inc. Announces Phase 1 and Phase 2 Data on KRX-0401 (Perifosine) in Patients with Relapsed/Refractory Multiple Myeloma at 49th Annual Meeting of American Society of Hematology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2008)...nstrates potent antiviral activity and favorable s...MBRIDGE, Mass., Sept. 4 /- ...iopharmaceutical company engaged,in the discovery ...n viral,and other infectious diseases, today annou...udy evaluating IDX899, a non-nucleoside reverse,tr...
(Date:9/4/2008)...s Remain on Schedule with Two Abstracts Accepted f...se in November 2008, BRIDGEWATER, N.J., Sept. 4 /...pecialty pharmaceutical company focused on the tre...day announced the appointment of,Peter L. Garrambo...er Garrambone,s career includes more than 50 pharm...
(Date:9/3/2008)...uestion Asked. Wrong Children Studied. Wrong,Concl...SNewswire/ -- A Centers for Disease,Control and Pr...s no link,between the MMR vaccine and autism. The ...does nothing to dispel the growing public concern ...l questions concerning design,and methodology., F...
(Date:9/3/2008)...ge of Rheumatology Research and Education Foundati... Advances in Detecting, Treati...wire/ -- For the first time during its,unprecedent...tis, the,American College of Rheumatology Research...tion acquired from research funded by the Within O...
Breaking Medicine Technology:Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 2Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 3Idenix Pharmaceuticals Announces Completion of Proof-of-Concept Study for IDX899 in Treatment-Naive HIV-Infected Patients 4Aegerion Pharmaceuticals, Inc. adds Peter Garrambone to Board of Directors, Secures Additional Capital for Clinical Trials 2CDC Misses Target With Flawed MMR/Autism Study 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 2New Research Shows Promise for Finding A Cure for Rheumatoid Arthritis 3Females avoid incest by causing male relatives to leave home 54 1Females avoid incest by causing male relatives to leave home 54 2Ambulatory oxygen rarely a benefit in COPD patients without resting hypoxemia 51 1Ambulatory oxygen rarely a benefit in COPD patients without resting hypoxemia 51 2First biomarker discovered that predicts prostate cancer outcome 48 1First biomarker discovered that predicts prostate cancer outcome 48 2First biomarker discovered that predicts prostate cancer outcome 48 3First biomarker discovered that predicts prostate cancer outcome 48 4Breast cancer prevention practices vary across Canada 45 1Breast cancer prevention practices vary across Canada 45 2
... Francophone du Myelome (IFM),Trial Presented Duri...ire-FirstCall/ --,Millennium Pharmaceuticals, Inc....e comparative Phase III clinical trial evaluating ...e myeloma (MM),patients. As induction therapy prio...based therapy produced a high complete remission,/...
...d Pivotal Phase 3 Trial CL-05, CHICAGO, July 02, 2...es Holdings, Inc. , today announced the confirmati... the first of two,pivotal Phase 3 clinical trials ... cethromycin, a novel once-a-day antibiotic, for,t.... The Company,also provided an update to the proje...
Other Medicine Technology:Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 2Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 3Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 4Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 5Velcade (bortezomib) for Injection Based Induction Therapy,Delivered High Post-Transplant Complete Remission Rate, a Critical,Marker for Increased Overall Survival 6Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 2Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 3Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 4Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 5Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 6Advanced Life Sciences Announces Supplemental Efficacy Data from,First Pivotal Phase 3 Pneumonia Clinical Trial 7
(Date:9/8/2008)...aser scalpels, arthroscopic,surgery, genomic resea...rinary medicine is quickly expanding into new high...e benefit; it,s improving medicine for,people, too... care for their pets to,treat diseases like diabet... according to the American Veterinary Medical Asso...
(Date:9/8/2008)...zine examines Iraq and Afghanistan veterans, strug..., Washington, DC (PRWEB) S...by veterans of the Iraq and Afghanistan wars about... addiction disorders are featured in the current i...ublication of the National Council for Community B...
(Date:9/7/2008)...f older patients successfully treated for colorect...le to detect any recurrence of cancer. The study, ... , a peer-reviewed journal of the American Cancer ...monitoring of colorectal cancer survivors could af...y curative surgery for colorectal cancer have an i...
(Date:9/7/2008)... appear to lower a man,s PSA level, the blood biom...her a man is at risk of prostate cancer. , But t.... 8 in the journal Cancer , caution that men shou... prostate cancer just yet. , "We showed that me...rin and other non-steroidal anti-inflammatory drug...
Breaking Medicine News(10 mins):Health News:High-Tech Vet Medicine Saving Lives of Pets and People 2Health News:Helping Veterans in Our Communities 2Health News:Helping Veterans in Our Communities 3Health News:Many colorectal cancer survivors do not receive recommended follow-up care 2Health News:Common painkillers lower levels of prostate cancer biomarker 2
... U.S prescription use released last week revealed ...tion// for Attention Deficiency Hyperactivity Diso...f a similar prescription themselves. In the year 2... children and their parents were studied by resear...
...tarted to dissuade and at times even forbid birthd...sity. // "They can bring carrots," said Laura Ott,...thday girl, Cassidy Stewart received a card, a sti...s from her classmates. Her school; Mission Viejo o...
...severe coronary artery disease live longer if they...nitial treatment // instead of artery-opening angi...University Medical Center analysis. Yet up to 40 ...ere coronary disease are treated first with angiop...
...a low-carb diet replacing starches and sugars with...hey may do something radically different. // A re...ests that the major change in eating patterns for ...been the addition of large amounts of vegetables a...
Other Medicine News:Health News:Bypass Surgery, a Better Option than Angioplasty for Severe Heart Patients 2Health News:Bypass Surgery, a Better Option than Angioplasty for Severe Heart Patients 3Health News:Low-Carb Dieters Eat More Vegetables 2
..., Available in even sizes 20-36F. Single use. A di...tient comfort. The Latex-Free Robertazzi is the id... the best solution for latex sensitivity. It is ec...latex-free product as your standard nasal airway c...
Soft red rubber. Adjustable flange. Pediatric sizes available.
Smooth flexible medical grade white low density polyethylene with reinforced block to prevent collapse.
Two-channel, Berman design. Semirigid, nontoxic polyethylene. Individually packaged, 48 per case. Latex Free.
Medicine Products: